
Swiss BioTech platform ASTRA Therapeutics raises €8.3 million to advance precision Parasiticides for animal health
Villigen-based ASTRA Therapeutics, a BioTech startup designing drugs against eukaryotic pathogens based on its proprietary platform, announced today they have raised a Seed funding round of €8.3 million. The round was led by VC firm MIG Capital AG, with U. …